[1]
2024. Efficacy of Deucravacitinib in Moderate to Severe Scalp Psoriasis: Analysis of Complete Clearance of Scalp Disease and Symptoms. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s430. DOI:https://doi.org/10.25251/skin.8.supp.430.